TB prevention strategies and unanswered questions for pregnant and postpartum women living with HIV: the need for improved evidence
暂无分享,去创建一个
[1] G. Montepiedra,et al. Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. , 2019, The New England journal of medicine.
[2] B. Richardson,et al. Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women. , 2019, Journal of acquired immune deficiency syndromes.
[3] M. Hughes,et al. Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons , 2019, PLoS medicine.
[4] R. Chaisson,et al. One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis , 2019, The New England journal of medicine.
[5] R. Chaisson,et al. Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials , 2018, Annals of the American Thoracic Society.
[6] M. Jansson,et al. Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting , 2018, PloS one.
[7] K. Dooley,et al. Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] B. Richardson,et al. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting , 2017, Journal of acquired immune deficiency syndromes.
[9] R. Chaisson,et al. Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons , 2016, AIDS.
[10] D. Fitzgerald,et al. Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women. , 2016, American journal of respiratory and critical care medicine.
[11] S. Hernández-Díaz,et al. Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] M. Kruijshaar,et al. Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. , 2012, American journal of respiratory and critical care medicine.
[13] Amita Gupta,et al. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] R. Bollinger,et al. Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Melissa R. Pfeiffer,et al. Tuberculosis prevention for non-US-born pregnant women. , 2006, American journal of obstetrics and gynecology.